Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: PCOR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on PCOR, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 12,048 PCOR shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 12,048 shares
    Change vs previous 13F -466,698 shares

    0.01% of the 13F portfolio, value $489,390.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 478,746 shares
    Change vs previous 13F -379,065 shares

    0.53% of the 13F portfolio, value $27,288,522.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 857,811 shares
    Change vs previous 13F +6,856 shares

    1.31% of the 13F portfolio, value $62,401,851.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 850,955 shares
    Change vs previous 13F +653,174 shares

    1.39% of the 13F portfolio, value $62,056,320.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 197,781 shares
    Change vs previous 13F +98,847 shares

    0.42% of the 13F portfolio, value $13,533,208.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 98,934 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $6,532,147.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).